Observational and retrospective study on the effect and safety of Tumor Treating Fields for newly diagnosed glioblastoma
Not Applicable
- Conditions
- Glioblastoma
- Registration Number
- JPRN-UMIN000041745
- Lead Sponsor
- Self funding
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 460
Inclusion Criteria
Not provided
Exclusion Criteria
1) Lesion was mainly located at cerebellum or brainstem 2) Patient with leptomeningeal dissemination 3) Patient with progressive disease during concomitant RT/Temozolomide 4) Patient who received bevacizumab
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall survival rate
- Secondary Outcome Measures
Name Time Method Overall survival rate of the subgroup classified by extent of resection, KPS, age, and implantation of BCNU wafers Adverse effect